ELMNT IR is redefining procedural medicine by establishing a new standard for minimally invasive care. We deliver advanced, image-guided treatments in a modern outpatient setting designed to be more efficient, integrated, and human than traditional hospital environments. Our mission is to make minimally invasive medicine the new default—elevating clinical outcomes and simplifying access for both patients and physicians.
We bridge the gap between institutional trust and modern efficiency. By blending clinical rigor with a streamlined outpatient model, we offer the technical depth of a major hospital alongside the seamless coordination of a specialized facility. This approach ensures an elevated standard of care, where procedures are performed with uncompromising precision and same-week consultations are the priority.
For patients, we offer an effective alternative to traditional surgery that typically results in less pain and a faster recovery. Our specialized treatments cover a wide range of needs, including vascular and men’s health, women’s health, oncology, and musculoskeletal pain. We focus on providing a smoother path back to life with significantly less disruption to your daily routine.
At our core is a commitment to partnership. We act as an extension of the referring physician’s practice, ensuring they remain the central coordinator of their patient’s journey. Led by experienced physicians and healthcare innovators, ELMNT IR is the evolution of how modern medicine should be delivered: precise, accessible, and centered on the human experience.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
What industry is ELMNT IR in?
ELMNT IR operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is ELMNT IR based?
ELMNT IR is headquartered in Los Angeles, United States.
Find investors for your startup like ELMNT IR
Gritt sends AI-personalised outreach to each investor — from your Gmail
